Results 61 to 70 of about 918 (92)

Conventional versus Monte Carlo SPECT reconstruction of Lu-177: Toward reduced bias and variance in quantitative imaging. [PDF]

Med Phys
Polson LA, Esquinas P, Kurkowska S, Li C, Uribe C, Rahmim A.   +5 more
europepmc   +1 more source

Emerging innovations in theranostics for pancreatic neuroendocrine tumors. [PDF]

NPJ Precis Oncol
Karimi A, Bogdani C, O'Dwyer E, Siolas D.   +3 more
europepmc   +1 more source

Radiation exposure and protection advice after [¹⁷⁷Lu]Lu-DOTA-TATE therapy in China. [PDF]

EJNMMI Res
Liu F, Li P, Xu J, Zhang J, Xu X, Chen Z, Qiao Y, Liang Y, Chen J, Song S.   +9 more
europepmc   +1 more source

Pyridyl-Ala in the third position of radiolabeled somatostatin antagonists: the effect of regioisomeric substitution. [PDF]

EJNMMI Radiopharm Chem
Mansi R, Bertarelli N, Del Pozzo L, Zanger S, Basaco Bernabeu T, Maecke H, Fani M.   +6 more
europepmc   +1 more source

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]

Theranostics
Zhang J, Mensel B, Baum RP.
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. [PDF]

Cancers (Basel)
Perrone E, Calcagni ML, Leccisotti L, Moretti R, Ghai K, Eismant A, Parkar T, Greifenstein L, Baum RP.   +8 more
europepmc   +1 more source

Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. [PDF]

Theranostics
Herr FL, Dascalescu C, Ebner R, Schnitzer ML, Fabritius MP, Schmid-Tannwald C, Zacherl MJ, Wenter V, Unterrainer LM, Brendel M, Holzgreve A, Werner RA, Auernhammer CJ, Spitzweg C, Knösel T, Burkard T, Ricke J, Heimer MM, Sheikh GT, Cyran CC.   +19 more
europepmc   +1 more source

Comparison of imaging-based bone marrow dosimetry methodologies and their dose-effect relationships in [¹⁷⁷Lu]Lu-PSMA-617 RLT including a novel method with active marrow localization. [PDF]

EJNMMI Phys
Peterson AB, Wilderman SJ, Blakkisrud J, Wong KK, Frey KA, Dewaraja YK.   +5 more
europepmc   +1 more source

Deciphering the Tumor Uptake of Heterobivalent (SST₂/Albumin) [⁶⁴Cu]Cu-NODAGA-cLAB-TATEs. [PDF]

J Med Chem
Brandt F, Ullrich M, Laube M, Löser R, Kotzerke J, Kopka K, Pietzsch J, van den Hoff J, Wodtke R.   +8 more
europepmc   +1 more source

Editorial: Recent advances in pheochromocytoma and paraganglioma: molecular pathogenesis, clinical impacts, and therapeutic perspective, volume II. [PDF]

Front Endocrinol (Lausanne)
Abe I, Islam F, Pillai S.
europepmc   +1 more source